查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012904

血袋市场：2026-2032年全球市场预测（按产品类型、灭菌方法、材料类型、填充容量、应用、最终用户和分销管道划分）

Blood Bags Market by Product Type, Sterilization Method, Material Type, Fill Volume, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血袋市场价值将达到 5.9009 亿美元，到 2026 年将成长至 6.2142 亿美元，到 2032 年将达到 9.6819 亿美元，复合年增长率为 7.32%。

主要市场统计数据
基准年 2025 590,090,000 美元
预计年份：2026年 6.2142亿美元
预测年份 2032 9.6819亿美元
复合年增长率 (%) 7.32%

背景概述，阐述了塑造现代血袋生态系统的临床重点、供应连续性挑战、监管限制和采购要求。

血袋产业处于临床安全、供应链复杂性以及不断发展的材料和灭菌技术的关键交汇点。现代医疗保健系统依赖可靠的血液收集、储存和输血耗材来支持急诊护理、择期手术和持续治疗性介入。因此，该行业的格局受到严格的监管要求、对可追溯性和无菌性的重视以及对能够应对突发需求激增的互通性供应网络的需求的影响。

材料创新、灭菌技术的进步、更严格的法规以及永续性的压力如何重塑产品设计、供应商趋势和筹资策略。

血袋市场正经历一场变革，其驱动力包括材料创新、灭菌技术进步以及监管力道加大。聚合物和添加剂的创新旨在提高生物相容性并减少渗漏，而替代灭菌方法则旨在保持组件完整性并延长保质期。同时，监管机构正在完善可追溯性和标籤要求，这增加了製造商和经销商的行政负担，同时也加速了标准化条码和电子追踪系统的应用。

本研究评估了累积关税波动和不断变化的贸易政策如何加剧供应链风险、影响製造业决策并迫使各行业调整其策略采购结构。

关税和贸易政策调整的累积影响正对血袋生态系统内的供应连续性、成本结构和筹资策略产生重大影响。关税调整增加了进口聚合物树脂、製造原材料和成品的接收成本，促使买家和製造商考虑近岸外包、双重采购和库存调整等缓解措施。同时，贸易规则变化带来的行政复杂性加剧了前置作业时间的波动，并使供应商资格合格流程更加复杂，尤其对于那些依赖跨境供应链获取关键零件的公司而言更是如此。

全面的细分洞察，揭示了产品、灭菌、材料、产能、应用、最终用户和分销管道等因素，指南优先顺序和创新决策。

详细的市场細項分析能够清楚阐明影响采购和产品开发决策的各项变量，例如产品、流程、材料、填充量、临床应用、最终用户和分销管道。根据产品类型，市场被细分为双联血袋、四联血袋、五联血袋、单联血袋和三联血袋，每种规格都有不同的临床工作流程相容性和成分分离要求。根据灭菌方法，市场细分为电子束灭菌、环氧乙烷灭菌、伽马射线灭菌和蒸气灭菌，灭菌方式的选择会影响产品的保存期限、成分完整性和验证的复杂性。根据材料类型，市场被细分为聚对苯二甲酸乙二醇酯 (PET)、聚烯、聚丙烯 (PP) 和聚氯乙烯(PVC)，材料的选择会影响产品的焊接性、透气渗透性以及与萃取物和洗脱液相关的监管审查。

区域分析概述了美洲、欧洲、中东和非洲以及亚太地区如何为供应商和买家创造独特的监管、商业和物流要求。

区域趋势对管理体制、供应商网路和临床部署路径有显着影响，从而在每个区域形成了独特的策略重点。在采购中心集中的美洲地区，联邦和州机构之间的监管协调至关重要，大规模医院网路和中央血库的推动使得与自动化血液成分分离技术的兼容性成为迫切需求。在欧洲、中东和非洲（EMEA）地区，多样化的报销模式、采购流程和分散的监管环境要求供应商在满足不同基础架构层的同时，保持灵活的监管策略和区域适应性的品管系统。在亚太地区，医疗保健系统的快速现代化和大规模公共卫生宣传活动需要扩充性的生产系统、经济高效的材料以及能够覆盖广阔地理区域的分销网络。

产业相关人员正在深入了解监管专业知识、生产规模、灭菌能力和供应链可靠性如何为竞争优势做出贡献。

随着老牌製造商、专业无菌组件製造商和契约製造製造商寻求差异化的价值提案，强调监管专业知识、成熟的品质系统和在地化生产能力，竞争格局正在改变。大型供应商利用规模经济，投资于流程自动化、拓展产品系列和全球品质标准化，而规模小规模的利基企业则凭藉敏捷性、专业化的产品形式和针对特定临床工作流程量身定制的本地化服务模式展开竞争。材料供应商和医疗设备製造商之间的策略伙伴关係日益普遍，这些合作正在加速材料合格，并缩短新产品上市前的合规时间。

为产业领导者提供切实可行的策略步骤，以加强监管合规性、实现製造地多元化、提高可追溯性并加强与供应商的伙伴关係。

产业领导者应采取多管齐下的策略，平衡创新、监管合作和供应链韧性，将当前压力转化为永续的竞争优势。优先发展能够预测监管预期并缩短新产品变更核准时间的材料和灭菌验证项目。同时，应实现製造地多元化或与区域契约製造製造商建立策略伙伴关係，以降低贸易政策风险并缩短前置作业时间。

透过结合相关人员访谈、监管分析和供应链诊断的透明混合研究途径，可以得出检验且可操作的见解。

本研究采用混合方法，结合质性专家访谈、监管文件分析和二手文献综述，综合得出结果，从而提供平衡且以证据为基础的观点。研究人员从临床医生、采购负责人、法规遵循专家和生产负责人处收集了关键的定性信息，以了解实际运营情况、产品性能预期和采购限制。为了补充这些访谈，研究人员还对监管指南、灭菌标准和材料安全评估进行了严格的分析，以检验技术假设并识别合规性方面的挑战。

简洁扼要的结论强调了材料、消毒、监管和供应链策略的关键交叉点，这些交叉点决定了韧性和竞争优势。

总而言之，由于材料科学、灭菌技术、法规和贸易政策趋势的不断发展，血袋产业正处于策略转折点，产品设计、供应商竞争和采购方式都受到了影响。积极主动地透过加强验证流程、实现采购多元化和提高可追溯性来适应变化的相关人员，将更有利于确保临床服务的连续性，并抓住源于产品差异化和服务卓越的成长机会。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 血袋市场：依产品类型划分

  • 两袋血袋
  • 四袋装血袋
  • 5个装血袋
  • 单血袋
  • 三袋血

第九章 依灭菌方法分類的血袋市场

  • 电子束
  • 环氧乙烷
  • 伽玛射线灭菌
  • 蒸气灭菌

第十章：血袋市场：依材料类型划分

  • 聚对苯二甲酸乙二醇酯（PET）
  • 聚烯
  • 聚丙烯（PP）
  • 聚氯乙烯（PVC）

第十一章 以填充容量分類的血包市场

  • 300～450 mL
  • 超过 450 毫升
  • 300毫升或以下

第十二章 血袋市场：依应用领域划分

  • 血液成分分离
  • 捐血
  • 血液保存
  • 输血

第十三章 血袋市场：依最终用户划分

  • 血库
  • 测试机构
  • 医院和诊所
  • 研究机构

第十四章 血袋市场：依通路划分

  • 离线
  • 在线的

第十五章 血袋市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 血袋市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 血袋市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国血袋市场

第十九章：中国血袋市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AdvaCare Pharma
  • Advin Health Care
  • Alvedia
  • BL Lifesciences Private Limited
  • Demophorius Limited
  • Fresenius SE & Co. KGaA
  • Grifols, SA
  • HAEMONETICS CORPORATION
  • HLL Lifecare Limited
  • HANSLER MEDICAL GMBH
  • Inovet
  • JMS Co., Ltd.
  • KIEFEL GmbH
  • Lmb Technologie GmbH
  • Maco Pharma SAS
  • Mitra Industries Pvt. Ltd.
  • Narang Medical Limited
  • Neomedic
  • Olidef Medical
  • Poly Medicure Limited
  • Qingdao Sinoland International Trade Co., Ltd.
  • RENOLIT SE
  • SB-Kawasumi Laboratories, Inc.
  • Shandong Weigao Group Medical Polymer Co.,Ltd.
  • Suru International Pvt. Ltd.
  • Suzhou Sinomed Co., Ltd.
  • Terumo Corporation
  • The Metrix Company
  • TROGE MEDICAL GmbH
  • Xindray Medical International Co., Ltd.
Product Code: MRR-437D45958098

The Blood Bags Market was valued at USD 590.09 million in 2025 and is projected to grow to USD 621.42 million in 2026, with a CAGR of 7.32%, reaching USD 968.19 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 590.09 million
Estimated Year [2026] USD 621.42 million
Forecast Year [2032] USD 968.19 million
CAGR (%) 7.32%

A contextual introduction that frames clinical priorities, supply continuity challenges, regulatory constraints, and procurement imperatives shaping the modern blood bags ecosystem

The blood bags sector occupies a critical intersection between clinical safety imperatives, supply chain complexity, and evolving material and sterilization technologies. Contemporary healthcare systems rely on robust blood collection, storage, and transfusion consumables to support emergency medicine, elective surgery, and ongoing therapeutic interventions. As a result, the landscape is shaped by rigorous regulatory expectations, an emphasis on traceability and sterility assurance, and the need for interoperable supply networks that can respond to episodic demand surges.

Over recent years, procurement teams and clinical leaders have prioritized product reliability, compatibility with component separation workflows, and supplier continuity. In addition, increased scrutiny on materials and sterilization pathways has influenced purchasing specifications and validation protocols. These dynamics are further complicated by global trade flows and regional regulatory divergence, requiring organizations to adopt more comprehensive sourcing strategies.

Given these complexities, stakeholders must balance clinical performance, patient safety, and logistical efficiency. Consequently, strategic planning now focuses on modular procurement, cross-compatible product suites, and enhanced supplier qualification processes. This introduction establishes a foundation for more detailed analysis of shifts in technology, trade policy impacts, segmentation patterns, and regional differentiators that follow in the subsequent sections.

How material innovation, sterilization advancements, regulatory tightening, and sustainability pressures are reshaping product design, supplier dynamics, and procurement strategies

The blood bags market is undergoing transformative shifts driven by material innovation, sterilization advances, and heightened regulatory scrutiny. Innovations in polymers and additive materials seek to improve biocompatibility and reduce leachables, while alternative sterilization methods aim to preserve component integrity and extend usable life. At the same time, regulatory authorities are refining traceability and labeling requirements, increasing the administrative burden on manufacturers and distributors and encouraging the adoption of standardized barcoding and electronic tracking systems.

As a result, suppliers are investing in process modernization and quality management systems to meet these expectations, which in turn reshapes competitive dynamics and entry barriers. Meanwhile, clinical pathways are adapting to new component separation techniques and single-donor processing protocols, prompting demand for product formats that offer greater modularity and compatibility with automated systems. These technological and regulatory currents are compounded by sustainability concerns that press manufacturers to reconsider material selection and end-of-life disposal practices.

Consequently, stakeholder strategies are shifting from transactional procurement to long-term partnerships centered on product lifecycle assurance, regulatory alignment, and operational resilience. In the near term, these converging trends will continue to influence product design priorities, capital investment decisions, and the configuration of distribution networks across both domestic and international channels.

Assessing how cumulative tariff shifts and evolving trade policies amplify supply chain risk, influence manufacturing decisions, and compel strategic sourcing adaptations across the industry

The cumulative impact of tariffs and trade policy recalibrations has material consequences for supply continuity, cost structures, and sourcing strategies within the blood bags ecosystem. Tariff adjustments increase landed costs for imported polymer resins, manufacturing inputs, and finished goods, prompting purchasers and manufacturers to evaluate nearshoring, dual-sourcing, and inventory rebalancing as mitigations. In parallel, administrative complexity stemming from changed trade rules elevates lead time variability and complicates supplier qualification processes, especially for entities that rely on cross-border supply chains for critical components.

As tariffs reshape the economics of manufacturing locations, some producers will reassess the viability of offshore production versus regional manufacturing footprints that reduce exposure to trade volatility. Procurement teams may prioritize suppliers with diversified manufacturing bases and transparent cost structures to maintain stable inventories and predictable pricing. Moreover, extended approval cycles and customs compliance requirements can delay product availability, which increases the importance of proactive regulatory engagement and scenario planning.

Therefore, organizations must integrate tariff sensitivity into commercial planning, supplier contracting, and contingency inventories. By doing so, they can protect clinical operations from supply disruption and support clinical continuity even as trade policies evolve. Ultimately, the cumulative effect of tariffs is to elevate strategic emphasis on supply chain resilience, regulatory agility, and collaborative supplier relationships.

Comprehensive segmentation insights that reveal product, sterilization, material, volume, application, end-user, and channel drivers which inform prioritization and innovation decisions

A granular segmentation view provides actionable clarity across product, process, material, fill volume, clinical application, end-user, and distribution channel variables that drive procurement and product development decisions. Based on Product Type, market is studied across Double Blood Bags, Quadruple Blood Bags, Quintuple Blood Bags, Single Blood Bags, and Triple Blood Bags, and each format presents different clinical workflow compatibility and component separation requirements. Based on Sterilization Method, market is studied across Electron Beam, Ethylene Oxide, Gamma Irradiation, and Steam Sterilization, and the selection of sterilization pathways impacts shelf life, component integrity, and validation complexity. Based on Material Type, market is studied across Polyethylene Terephthalate (PET), Polyolefin, Polypropylene (PP), and Polyvinyl Chloride (PVC), and material choice affects weldability, gas permeability, and regulatory scrutiny regarding extractables and leachables.

Based on Fill Volume, market is studied across 300-450 mL, Above 450 mL, and Up To 300 mL, and volume preferences correlate with procedural use cases and donor management protocols. Based on Application, market is studied across Blood Component Separation, Blood Donation, Blood Storage, and Blood Transfusion, and these applications impose distinct design and compatibility specifications. Based on End User, market is studied across Blood Banks, Diagnostic Laboratories, Hospitals & Clinics, and Research Institutes, and each end-user group prioritizes different performance attributes, inventory models, and regulatory compliance needs. Based on Distribution Channel, market is studied across Offline and Online, and channel selection influences lead times, contract terms, and aftermarket services.

Together, these segmentation lenses clarify where innovation and investment will have the greatest operational impact, enabling product teams and procurement leaders to align development roadmaps and sourcing strategies with specific clinical and logistical requirements.

Regional analysis outlining how Americas, Europe, Middle East & Africa, and Asia-Pacific each create unique regulatory, commercial, and logistical imperatives for suppliers and purchasers

Regional dynamics exert a pronounced influence on regulatory regimes, supplier networks, and clinical adoption pathways, producing distinct strategic priorities in each geography. Americas demonstrates concentrated procurement hubs, an emphasis on regulatory harmonization across federal and state agencies, and a strong demand for compatibility with automated blood component separation technologies driven by large hospital networks and centralized blood centers. Europe, Middle East & Africa presents a fragmented regulatory landscape with varying reimbursement models and procurement processes, requiring suppliers to maintain flexible regulatory strategies and localized quality systems while addressing diverse clinical infrastructure levels. Asia-Pacific displays a mix of rapidly modernizing healthcare systems and high-volume public health campaigns that prioritize scalable production, cost-effective materials, and distribution networks capable of servicing wide geographic territories.

As a consequence, manufacturers and distributors must tailor commercial models to regional realities, investing in targeted regulatory dossiers, localized customer support, and supply chain nodes that reduce lead times. In addition, cross-regional partnerships and contract manufacturing arrangements can bridge capability gaps and ensure continuity of supply during demand surges or regulatory transitions. Ultimately, recognizing and responding to these regional differentiators is essential for sustained commercial performance and for meeting the varied clinical requirements across different health systems.

Insights into how competitive advantages are shaped by regulatory expertise, manufacturing scale, sterilization capability, and supply chain reliability among industry participants

Competitive dynamics are evolving as established manufacturers, specialized sterile component producers, and contract manufacturers pursue differentiated value propositions that emphasize regulatory expertise, quality system maturity, and local manufacturing capabilities. Large-tier suppliers leverage scale to invest in process automation, extended product portfolios, and global quality harmonization, while smaller niche players compete through agility, specialized product formats, and localized service models that meet specific clinical workflows. Strategic partnerships between material suppliers and device manufacturers are becoming more common, and these collaborations accelerate material qualification and reduce time-to-compliance for new product introductions.

Moreover, investments in sterilization capacity and validation services give suppliers advantages in contracts that require expedited qualification paths or bespoke sterilization solutions. Distribution partners with proven cold chain and logistics capabilities differentiate themselves by reducing inventory risk and improving replenishment predictability for high-volume end users. Consequently, the competitive landscape rewards firms that combine technical differentiation with supply chain reliability and regulatory responsiveness. For customers, this means that supplier selection increasingly hinges on demonstrable quality performance, transparency in supply provenance, and the ability to provide end-to-end lifecycle support.

Actionable strategic steps for industry leaders to strengthen regulatory readiness, diversify manufacturing footprints, enhance traceability, and fortify supplier partnerships

Industry leaders should adopt a multi-pronged strategy that balances innovation, regulatory engagement, and supply chain resilience to convert current pressures into durable competitive advantages. Prioritize material and sterilization validation programs that anticipate regulatory expectations and reduce time-to-approval for new product variants. Simultaneously, diversify manufacturing footprints or establish strategic partnerships with regional contract manufacturers to mitigate trade policy exposure and compress lead times.

In parallel, invest in traceability and digital inventory systems that support clinical traceability and enable predictive replenishment across distributed networks. Strengthen supplier qualification criteria to include contingency capacity, multi-region production capability, and transparent cost components tied to trade sensitivities. Finally, develop commercial models that emphasize lifecycle services, training, and interoperability with component separation systems, thereby increasing switching costs for buyers and deepening collaborative relationships.

By implementing these initiatives, industry leaders can protect clinical continuity, support regulatory compliance, and create differentiated offerings that align with evolving hospital and blood center priorities. These recommendations translate strategic intent into operational steps that support both near-term risk mitigation and sustained market positioning.

A transparent mixed-methods research approach combining stakeholder interviews, regulatory analysis, and supply chain diagnostics to produce validated actionable insights

This research synthesis is grounded in a mixed-methods approach that combined qualitative expert interviews, regulatory document analysis, and secondary literature review to produce a balanced, evidence-based perspective. Primary qualitative inputs were collected from clinicians, procurement professionals, regulatory affairs specialists, and manufacturing leaders to capture operational realities, product performance expectations, and sourcing constraints. Complementing these interviews, rigorous analysis of regulatory guidance, sterilization standards, and material safety assessments was conducted to validate technical assumptions and identify compliance-related pressures.

Additionally, supply chain diagnostic workstreams examined trade flows, manufacturing footprints, and distribution channel architectures to surface vulnerability points and resilience opportunities. Where appropriate, triangulation across independent data sources ensured that observations reflect convergent evidence rather than isolated anecdotes. Throughout the process, emphasis was placed on transparency of assumptions and reproducibility of analytical steps, enabling readers to trace how conclusions were derived and to adapt the methodology for bespoke follow-on studies.

This methodology supports strategic decision-making by combining operational insight with technical validation, providing stakeholders with a robust basis for procurement, product development, and regulatory engagement activities.

A concise conclusion emphasizing the critical intersection of material, sterilization, regulatory, and supply chain strategies that determine resilience and competitive positioning

In summary, the blood bags sector is at a strategic inflection point where material science, sterilization practice, regulatory evolution, and trade policy dynamics collectively influence product design, supplier competition, and procurement approaches. Stakeholders who proactively adapt by strengthening validation pathways, diversifying sourcing footprints, and enhancing traceability will be better positioned to ensure clinical continuity and capture growth opportunities rooted in product differentiation and service excellence.

Moving forward, the interplay between regional regulatory frameworks and supply chain configuration will determine competitive advantage, and organizations that invest in regional manufacturing partnerships and robust quality systems will mitigate disruption risk. In addition, a focus on interoperable product formats and lifecycle support services will increase the value proposition for clinical buyers, fostering longer-term relationships and more predictable demand patterns.

Ultimately, disciplined execution of the strategies and recommendations outlined herein will enable organizations to navigate near-term headwinds while investing in capabilities that sustain long-term operational resilience and clinical alignment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Bags Market, by Product Type

  • 8.1. Double Blood Bags
  • 8.2. Quadruple Blood Bags
  • 8.3. Quintuple Blood Bags
  • 8.4. Single Blood Bags
  • 8.5. Triple Blood Bags

9. Blood Bags Market, by Sterilization Method

  • 9.1. Electron Beam
  • 9.2. Ethylene Oxide
  • 9.3. Gamma Irradiation
  • 9.4. Steam Sterilization

10. Blood Bags Market, by Material Type

  • 10.1. Polyethylene Terephthalate (PET)
  • 10.2. Polyolefin
  • 10.3. Polypropylene (PP)
  • 10.4. Polyvinyl Chloride (PVC)

11. Blood Bags Market, by Fill Volume

  • 11.1. 300-450 mL
  • 11.2. Above 450 mL
  • 11.3. Up To 300 mL

12. Blood Bags Market, by Application

  • 12.1. Blood Component Separation
  • 12.2. Blood Donation
  • 12.3. Blood Storage
  • 12.4. Blood Transfusion

13. Blood Bags Market, by End User

  • 13.1. Blood Banks
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals & Clinics
  • 13.4. Research Institutes

14. Blood Bags Market, by Distribution Channel

  • 14.1. Offline
  • 14.2. Online

15. Blood Bags Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Blood Bags Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Blood Bags Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Blood Bags Market

19. China Blood Bags Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AdvaCare Pharma
  • 20.6. Advin Health Care
  • 20.7. Alvedia
  • 20.8. B L Lifesciences Private Limited
  • 20.9. Demophorius Limited
  • 20.10. Fresenius SE & Co. KGaA
  • 20.11. Grifols, S.A
  • 20.12. HAEMONETICS CORPORATION
  • 20.13. HLL Lifecare Limited
  • 20.14. HANSLER MEDICAL GMBH
  • 20.15. Inovet
  • 20.16. JMS Co., Ltd.
  • 20.17. KIEFEL GmbH
  • 20.18. Lmb Technologie GmbH
  • 20.19. Maco Pharma SAS
  • 20.20. Mitra Industries Pvt. Ltd.
  • 20.21. Narang Medical Limited
  • 20.22. Neomedic
  • 20.23. Olidef Medical
  • 20.24. Poly Medicure Limited
  • 20.25. Qingdao Sinoland International Trade Co., Ltd.
  • 20.26. RENOLIT SE
  • 20.27. SB-Kawasumi Laboratories, Inc.
  • 20.28. Shandong Weigao Group Medical Polymer Co.,Ltd.
  • 20.29. Suru International Pvt. Ltd.
  • 20.30. Suzhou Sinomed Co., Ltd.
  • 20.31. Terumo Corporation
  • 20.32. The Metrix Company
  • 20.33. TROGE MEDICAL GmbH
  • 20.34. Xindray Medical International Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD BAGS MARKET SIZE, BY DOUBLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD BAGS MARKET SIZE, BY DOUBLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD BAGS MARKET SIZE, BY DOUBLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD BAGS MARKET SIZE, BY QUADRUPLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD BAGS MARKET SIZE, BY QUADRUPLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD BAGS MARKET SIZE, BY QUADRUPLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD BAGS MARKET SIZE, BY QUINTUPLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD BAGS MARKET SIZE, BY QUINTUPLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD BAGS MARKET SIZE, BY QUINTUPLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD BAGS MARKET SIZE, BY SINGLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD BAGS MARKET SIZE, BY SINGLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD BAGS MARKET SIZE, BY SINGLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD BAGS MARKET SIZE, BY TRIPLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD BAGS MARKET SIZE, BY TRIPLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD BAGS MARKET SIZE, BY TRIPLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD BAGS MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD BAGS MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD BAGS MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD BAGS MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD BAGS MARKET SIZE, BY GAMMA IRRADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD BAGS MARKET SIZE, BY GAMMA IRRADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD BAGS MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD BAGS MARKET SIZE, BY STEAM STERILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD BAGS MARKET SIZE, BY STEAM STERILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE (PET), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYPROPYLENE (PP), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYPROPYLENE (PP), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD BAGS MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD BAGS MARKET SIZE, BY 300-450 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD BAGS MARKET SIZE, BY 300-450 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD BAGS MARKET SIZE, BY 300-450 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD BAGS MARKET SIZE, BY ABOVE 450 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD BAGS MARKET SIZE, BY ABOVE 450 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD BAGS MARKET SIZE, BY ABOVE 450 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD BAGS MARKET SIZE, BY UP TO 300 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD BAGS MARKET SIZE, BY UP TO 300 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD BAGS MARKET SIZE, BY UP TO 300 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD DONATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD DONATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD DONATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD BAGS MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD BAGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD BAGS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD BAGS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD BAGS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD BAGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD BAGS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD BAGS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD BAGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD BAGS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD BAGS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BLOOD BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. GCC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GCC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. GCC BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 164. GCC BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 166. GCC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GCC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. GCC BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. G7 BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. G7 BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. G7 BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 188. G7 BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 190. G7 BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. G7 BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. G7 BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. NATO BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. NATO BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. NATO BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. NATO BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 198. NATO BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. NATO BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. NATO BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA BLOOD BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA BLOOD BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA BLOOD BAGS MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA BLOOD BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)